5-25 | Resolution passes at World Health Assembly, calling for more affordable vaccines and greater transparency on vaccine pricing
3-25 | Indian generic companies should reject Gilead’s controversial hepatitis C programmeProgramme could compromise patient treatment and privacy rights Ahead of a meeting in Jaipur, India this week between US pharmaceutical company Gilead Sciences and several Indian companies which have entered into an agreement with Gilead to produce hepatitis C drugs, Médecins Sans Frontières/Doctors Without Borders (MSF) urged the generic companies to reject a high
MSF calls on GSK and Pfizer to slash pneumo vaccine price to $5 per child for poor countries ahead of donor meeting
1-16 | New MSF report reveals countries struggle with skyrocketing vaccine prices amidst market shrouded in secrecy Médecins Sans Frontières (MSF) today called on pharmaceutical companies GlaxoSmithKline (GSK) and Pfizer to slash the price of the pneumococcal vaccine to US$5 per child in developing countries, ahead of a major vaccination donor conference in Berlin.
11-28 | The call by UNAIDS to "close the gap" around access to HIV services will not be met unless the delivery of antiretroviral treatment (ARV) is radically reshaped into community-led approaches that adapt to the realities of those living with HIV, warns Médecins sans Frontières/Doctors without Borders (MSF) ahead of World Aids day (1st December). MSF's and other organizations' first-hand experience has shown that community approaches that make access to ARVs easier and less costly for people are key strategies w
9-2 | Following months of intense conflict, an increasingly alarming humanitarian situation is unfolding in eastern Ukraine, Medecins Sans Frontieres (MSF) said.